InterCure is a pharmaceutical-grade cannabis producer and distributor operating primarily in Israel through its subsidiary Canndoc, with production facilities using climate-controlled greenhouse cultivation technology and GMP-certified processes meeting EU and Israeli regulatory standards. The company produces and distributes standardized cannabis products in two formats—dried inflorescences and cannabis extract oils—characterized by reproducible cannabinoid profiles, selling primarily through a vertically integrated network of company-owned and franchised pharmacies, licensed wholesalers, and pharmacy chains in Israel, with emerging international partnerships in regulated markets across Europe, Australia, and Canada. Revenue derives from direct sales to licensed pharmacies and distributors, retail pharmacy operations, wholesale distribution, and strategic licensing agreements with international cannabis brands.